GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $90.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective boosted by Royal Bank Of Canada from $80.00 to $90.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

A number of other research firms have also recently weighed in on GEHC. Bank of America reissued a “neutral” rating on shares of GE HealthCare Technologies in a report on Thursday. Wolfe Research started coverage on shares of GE HealthCare Technologies in a report on Tuesday, October 20th. They issued a “peer perform” rating for the company. Oppenheimer reaffirmed an “outperform” rating on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Weiss Ratings raised shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $93.00 price target on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $80.57.

GE HealthCare Technologies Trading Up 0.2%

GEHC opened at $76.57 on Thursday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.30. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77. The company has a market cap of $34.62 billion, a P/E ratio of 16.15, a PEG ratio of 1.99 and a beta of 0.73. The business’s 50-day simple moving average is $68.45 and its 200-day simple moving average is $70.06.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.14. The firm had revenue of $5.51 billion during the quarter, compared to analysts’ expectations of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.07 earnings per share. As a group, equities research analysts expect that GE HealthCare Technologies will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.04 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.38%.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors have recently modified their holdings of the business. State Street Corp grew its holdings in shares of GE HealthCare Technologies by 1.6% in the 2nd quarter. State Street Corp now owns 20,861,566 shares of the company’s stock worth $1,335,349,000 after acquiring an additional 323,090 shares during the period. Barrow Hanley Mewhinney & Strauss LLC increased its stake in GE HealthCare Technologies by 13.2% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock valued at $861,307,000 after purchasing an additional 1,571,226 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in GE HealthCare Technologies by 2.0% during the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after purchasing an additional 105,995 shares during the last quarter. Van ECK Associates Corp raised its holdings in GE HealthCare Technologies by 4.1% during the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after purchasing an additional 177,028 shares during the last quarter. Finally, Mizuho Markets Cayman LP raised its holdings in GE HealthCare Technologies by 173.2% during the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock worth $218,416,000 after purchasing an additional 1,945,500 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong Q3 results beat expectations. GE HealthCare reported $5.51 billion in revenue, above the $5.35 billion consensus estimate, while EPS of $1.34 exceeded expectations of $1.20. Revenue increased 7.2% year over year, helping drive the post-earnings gap higher. GE HealthCare Technologies Shares Gap Up After Strong Earnings
• Positive Sentiment: Management raised its full-year outlook. The company now expects approximately 4% organic revenue growth, adjusted EPS of $4.95–$5.05, and at least $1.6 billion in free cash flow. Organic growth of 6.2% and margin expansion in the quarter further strengthened the bullish case. GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
• Positive Sentiment: Analysts raised valuation targets. RBC increased its target from $80 to $90 and maintained an “outperform” rating. BNP Paribas lifted its target from $96 to $100, while Mizuho raised its target from $85 to $90. BTIG Research also forecast substantial potential appreciation. BNP Paribas Price Target Update
• Neutral Sentiment: JPMorgan raised its price target from $70 to $80 but kept a “neutral” rating, suggesting recognition of the earnings improvement while retaining a cautious stance on valuation. JPMorgan GE HealthCare Rating
• Neutral Sentiment: A value comparison with Haemonetics highlights GEHC’s investment appeal but does not introduce a material new catalyst for the stock. GEHC Versus HAE Value Comparison

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.